In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
深入研究IGM Biosciences的6条分析师建议
IGM Biosciences (NASDAQ:IGMS) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有6位分析师对IGM Biosciences（纳斯达克股票代码：IGMS）进行了分析，揭示了从看涨到看跌的不同观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for IGM Biosciences, presenting an average target of $16.17, a high estimate of $21.00, and a low estimate of $12.00. Marking an increase of 131.0%, the current average surpasses the previous average price target of $7.00.
在对12个月目标股价的评估中，分析师公布了对IGM Biosciences的见解，平均目标股价为16.17美元，最高估计为21.00美元，低估值为12.00美元。当前的平均价格上涨了131.0％，超过了之前的平均目标股价7.00美元。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
A comprehensive examination...
对金融...
登录免费看全文
登录/注册